By Memorandum Opinion entered by The Honorable Colm F. Connolly in Pharmacyclics LLC et al. v. Alvogen Pine Brook LLC et al., Civil Action No. 19-0434-CFC-CJB (D.Del. August 19,
Continue Reading Chief Judge Connolly Issues Comprehensive Opinion Setting Forth Court’s Findings of Fact and Conclusions of Law on Infringement Claims and Invalidity Defenses as to Patents-in-Suit Following ANDA Trial
obviousness
Chief Judge Stark Finds that Defendant Hospira Does Not Infringe Plaintiff Belcher’s Patent-in-Suit and Patent is Invalid and Unenforceable
By Fox Rothschild LLP on
By Opinion entered by The Honorable Leonard P. Stark in Belcher Pharmaceutical, LLC v. Hospira, Inc., Civil Action No. 17-775-LPS (D.Del. March 31, 2020), following a two day bench…
Continue Reading Chief Judge Stark Finds that Defendant Hospira Does Not Infringe Plaintiff Belcher’s Patent-in-Suit and Patent is Invalid and Unenforceable
Judge Noreika Denies Plaintiffs’ Motion for Preliminary Injunction Seeking to Deny the U.S. Manufacture of Defendants’ Competing Device Based on Patent Infringement
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Maryellen Noreika in Abbott Cardiovascular Systems, Inc. et al. v. Edwards Lifesciences Corp. et al., Civil Action No. 19-149-MN (D.Del. June 6,…
Continue Reading Judge Noreika Denies Plaintiffs’ Motion for Preliminary Injunction Seeking to Deny the U.S. Manufacture of Defendants’ Competing Device Based on Patent Infringement
Judge Sleet Denies Defendant’s Motion for Judgment as a Matter of Law Following Jury Verdict in Plaintiffs’ Favor in Patent Infringement Action
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Green Mountain Glass LLC & Culchrome LLC v. Saint-Gobain Containers, Inc. d/b/a Veralla North America, Civil Action No.
Continue Reading Judge Sleet Denies Defendant’s Motion for Judgment as a Matter of Law Following Jury Verdict in Plaintiffs’ Favor in Patent Infringement Action
Judge Sleet Invalidates Patents-in-Suit After Finding of Obviousness and Enters Judgment in Favor of Alleged Infringer in Hatch-Waxman Action
By Fox Rothschild LLP on
Following a five-day bench trial in the matter in February 2017 and after having considered the entire record in the case and the applicable law, the Court, through Memorandum, entered…
Continue Reading Judge Sleet Invalidates Patents-in-Suit After Finding of Obviousness and Enters Judgment in Favor of Alleged Infringer in Hatch-Waxman Action
Judge Andrews Concludes that Defendants Failed to Prove Affirmative Defenses of Obviousness and Implied License in ANDA Action
By Fox Rothschild LLP on
By Trial Opinion entered by The Honorable Richard G. Andrews, following a bench trial, in Endo Pharmaceuticals Inc. et al. v. Amneal Pharmaceuticals, LLC et al., Civil Action No.
Continue Reading Judge Andrews Concludes that Defendants Failed to Prove Affirmative Defenses of Obviousness and Implied License in ANDA Action
Judge Sleet Concludes that Defendants Did Not Prove Invalidity of Asserted Claim in ANDA Action
By Fox Rothschild LLP on
Following a four day bench trial in a consolidated ANDA action before The Honorable Gregory M. Sleet in Genzyme Corp., et al. v. Dr. Reddy’s Laboratories, Ltd., et al.,…
Continue Reading Judge Sleet Concludes that Defendants Did Not Prove Invalidity of Asserted Claim in ANDA Action
Judge Sleet Denies Defendants’ Post-Trial Proposed Finding of Invalidity of Patents-in-Suit Due To Obviousness
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Pfizer Inc. v. Sandoz Inc., et al., Civil Action No. 13-110-GMS (D.Del., Apr. 20, 2016), the Court denied…
Continue Reading Judge Sleet Denies Defendants’ Post-Trial Proposed Finding of Invalidity of Patents-in-Suit Due To Obviousness
After Bench Trial, Judge Sleet Concludes that None of the Asserted Claims of the Patents-in-Suit Are Invalid Due to Obviousness
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Pfizer Inc., et al. v. Mylan Pharmaceuticals Inc., C.A. No. 10-528-GMS (D.Del., October 22, 2014), the Court, following…
Continue Reading After Bench Trial, Judge Sleet Concludes that None of the Asserted Claims of the Patents-in-Suit Are Invalid Due to Obviousness
After Bench Trial, Judge Sleet Concludes that Hospira’s Proposed Product Does Not Infringe the Patent-in-Suit Asserted by Abbvie
By Fox Rothschild LLP on
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Abbvie Inc. v. Hospira, Inc., C.A. No. 11-648- GMS (D.Del., October 24, 2014), the Court, following a two…
Continue Reading After Bench Trial, Judge Sleet Concludes that Hospira’s Proposed Product Does Not Infringe the Patent-in-Suit Asserted by Abbvie